(IN BRIEF) Novo Nordisk has received approval from the European Medicines Agency to update the delivery conditions for Wegovy® injection, allowing it to be transported at temperatures of up to 30°C for up to 48 hours. This makes it the … Read the full press release →
Posted in Business, Denmark, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged cardiovascular risk reduction, cold chain distribution, digital health, direct to patient delivery, eHealth, EMA approval, Europe pharmaceutical regulation, European Medicines Agency, GLP-1 treatment, healthcare supply chain, home delivery medicines, MASH treatment, Mike Doustdar, Novo Nordisk, Novo Nordisk Advances European Access to Wegovy with New 48-Hour Controlled Temperature Delivery Approval, Obesity Treatment, pharmaceutical logistics, Semaglutide, Wegovy, weight management
(IN BRIEF) Roche, a leading pharmaceutical company, has announced its definitive merger agreement to acquire Carmot Therapeutics, a privately owned US-based company specializing in obesity treatment and related metabolic diseases. The acquisition includes Carmot’s portfolio of clinical stage subcutaneous and … Read the full press release →
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged acquisition, Carmot Therapeutics, CT-388, Levi Garraway, metabolic disease, Obesity Treatment, Roche, Thomas Schinecker, USA
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
